Cotton Cary C, Eluri Swathi, Wolf W Asher, Dellon Evan S
Division of Gastroenterology and Hepatology, Department of Medicine, Center for Esophageal Diseases and Swallowing, University of North Carolina at Chapel Hill, CB # 7080, Bioinformatics Bldg, 130 Mason Farm Rd, Chapel Hill, NC, 27599-7080, USA.
Dig Dis Sci. 2017 Sep;62(9):2408-2420. doi: 10.1007/s10620-017-4642-7. Epub 2017 Jun 12.
Topical corticosteroids or six-food elimination diet is recommended as initial therapy for eosinophilic esophagitis (EoE).
We aimed to summarize published manuscripts that report outcomes of these therapies for EoE.
We performed a systematic review in MEDLINE, Web of Science, and Embase of published manuscripts describing topical fluticasone, topical budesonide, and six-food elimination diet as therapies for EoE. We conducted meta-analysis of symptom improvement and the change in peak mucosal eosinophil count, with heterogeneity between studies examined with meta-regression analysis.
Systematic review yielded 51 articles that met inclusion criteria. Summary histologic response rates were 68.3% [95% prediction limits (PL) 16.2-96.0%] for fluticasone, 76.8% (95% PL 36.1-95.1%) for budesonide, and 69.0% (95% PL 31.9-91.4%) for six-food elimination diet. Corresponding decreases in eosinophil counts were 37.8 (95% PL 19.0-56.7), 62.5 (95% PL 125.6 to -0.67, and 44.6 (95% PL 26.5-62.7), respectively. Symptom response rates were 82.3% (95% PL 68.1-91.1%), 87.9% (95% PL 42.7-98.6%), and 87.3% (95% PL 64.5-96.3%), respectively. Meta-regression analyses decreased the initially large estimate of residual heterogeneity and suggested differences in histologic response rate associated with study populations' baseline eosinophil count and age.
The literature describing topical corticosteroids and six-food elimination diet consists of small studies with diverse methods and population characteristics. Meta-analysis with meta-regression shows initial histologic and symptomatic response rates on the same order of magnitude for topical corticosteroids and six-food elimination diet, but heterogeneity of study designs prevents direct comparison of modalities.
外用糖皮质激素或六种食物排除饮食被推荐作为嗜酸性粒细胞性食管炎(EoE)的初始治疗方法。
我们旨在总结已发表的报告这些治疗EoE疗效的手稿。
我们在MEDLINE、科学网和Embase中对已发表的将外用氟替卡松、外用布地奈德和六种食物排除饮食作为EoE治疗方法的手稿进行了系统评价。我们对症状改善情况和黏膜嗜酸性粒细胞峰值计数变化进行了荟萃分析,并通过荟萃回归分析研究了各研究之间的异质性。
系统评价产生了51篇符合纳入标准的文章。氟替卡松的组织学总反应率为68.3%[95%预测区间(PL)16.2 - 96.0%],布地奈德为76.8%(95%PL 36.1 - 95.1%),六种食物排除饮食为69.0%(95%PL 31.9 - 91.4%)。嗜酸性粒细胞计数相应下降分别为37.8(95%PL 19.0 - 56.7)、62.5(95%PL 125.6至 - 0.67)和44.6(95%PL 26.5 - 62.7)。症状反应率分别为82.3%(95%PL 68.1 - 91.1%)、87.9%(95%PL 42.7 - 98.6%)和87.3%(95%PL 64.5 - 96.3%)。荟萃回归分析降低了最初对残余异质性的较大估计,并提示组织学反应率的差异与研究人群的基线嗜酸性粒细胞计数和年龄有关。
描述外用糖皮质激素和六种食物排除饮食的文献由方法和人群特征各异的小型研究组成。采用荟萃回归分析的荟萃分析显示,外用糖皮质激素和六种食物排除饮食的初始组织学和症状反应率处于同一数量级,但研究设计的异质性妨碍了对不同治疗方式的直接比较。